We are live on
!
Find out more
A
AustralianSuper Portfolio holdings
AUM
$19.2B
1-Year Est. Return
31.95%
This Fund
S&P 500
This Quarter
Est. Return
-15.67%
1 Year Est. Return
+31.95%
3 Year Est. Return
+101.58%
5 Year Est. Return
+115.19%
10 Year Est. Return
–
AUM
$16.2M
AUM Growth
-$2.2M
(-12%)
Cap. Flow
+$1.07B
Cap. Flow
% of AUM
6,600.01%
Top 10 Holdings %
Top 10 Hldgs %
35.09%
Holding
198
New
16
Increased
100
Reduced
56
Closed
23
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intuit
INTU
|
+$255M |
| 2 |
Bio-Rad Laboratories Class A
BIO
|
+$202M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$174M |
| 4 |
Apple
AAPL
|
+$167M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$128M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Estee Lauder
EL
|
+$171M |
| 2 |
Veeva Systems
VEEV
|
+$170M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$169M |
| 4 |
VF Corp
VFC
|
+$123M |
| 5 |
Adobe
ADBE
|
+$110M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.37% |
| 2 | Healthcare | 17.3% |
| 3 | Financials | 13.99% |
| 4 | Consumer Discretionary | 12.99% |
| 5 | Materials | 10.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Hewlett Packard
HPE
$60.7B
| $45.3K | 0.28% |
3,418,219
+398,703
| +13% | +$6.05M |
|
77
NetApp
NTAP
$32.1B
| $44.4K | 0.27% |
680,386
+153,599
| +29% | +$11M |
|
78
Nucor
NUE
$53.9B
| $44.3K | 0.27% |
424,182
+131,918
| +45% | +$17.9M |
|
79
Seagate
STX
$178B
| $44K | 0.27% |
615,828
+183,371
| +42% | +$14.9M |
|
80
ON Semiconductor
ON
$34B
| $42.6K | 0.26% |
845,914
+73,408
| +10% | +$4.09M |
|
81
Magna International
MGA
$18.1B
| $42.2K | 0.26% |
768,140
+102,736
| +15% | +$6.26M |
|
82
RTX Corp
RTX
$261B
| $41.1K | 0.25% |
428,142
+28,593
| +7% | +$2.75M |
|
83
Textron
TXT
$15.9B
| $39.8K | 0.25% |
651,572
+125,507
| +24% | +$8.23M |
|
84
Automatic Data Processing
ADP
$102B
| $39.7K | 0.25% |
189,150
+151,182
| +398% | +$33.1M |
|
85
Stellantis
STLA
$16.8B
| $38.7K | 0.24% |
3,132,376
+959,401
| +44% | +$13.6M |
|
86
Regeneron Pharmaceuticals
REGN
$70.9B
| $38K | 0.23% |
+64,277
| New | +$41.8M |
|
87
Incyte
INCY
$23.4B
| $36.8K | 0.23% |
484,153
+91,090
| +23% | +$6.92M |
|
88
Quest Diagnostics
DGX
$23.3B
| $36.1K | 0.22% |
271,592
+112,672
| +71% | +$15.4M |
|
|
HOLX
89
DELISTED
Hologic
HOLX
| $35.1K | 0.22% |
506,454
-180,450
| -26% | -$13.4M |
|
90
Waters Corp
WAT
$36.2B
| $34.9K | 0.22% |
105,552
-12,840
| -11% | -$4.08M |
|
91
Gen Digital
GEN
$16.1B
| $34.4K | 0.21% |
1,567,112
+438,282
| +39% | +$10.8M |
|
92
Lumen
LUMN
$6.47B
| $30.5K | 0.19% |
2,793,546
+254,189
| +10% | +$2.85M |
|
93
Fidelity National Financial
FNF
$14B
| $30.2K | 0.19% |
849,997
+189,739
| +29% | +$7.42M |
|
94
Fidelity National Information Services
FIS
$21.7B
| $29.8K | 0.18% |
324,709
+277,981
| +595% | +$27.6M |
|
95
Snap-on
SNA
$21.3B
| $29.7K | 0.18% |
150,685
+7,165
| +5% | +$1.53M |
|
96
Moody's
MCO
$89.2B
| $29.5K | 0.18% |
108,418
+56,720
| +110% | +$17M |
|
97
Steel Dynamics
STLD
$34B
| $29.2K | 0.18% |
441,164
+66,971
| +18% | +$5.36M |
|
98
Molina Healthcare
MOH
$11.7B
| $28.8K | 0.18% |
102,949
-32,838
| -24% | -$9.92M |
|
99
Whirlpool
WHR
$2.48B
| $28.5K | 0.18% |
184,158
+53,102
| +41% | +$9.23M |
|
100
Celanese
CE
$5.01B
| $27.3K | 0.17% |
231,903
+160,205
| +223% | +$23M |
|
Similar funds
CS
LF
PCM
MGP
SOMRS
BPA
NAM
AustralianSuper's Q2 2022 Portfolio in Review
As of Q2 2022, AustralianSuper held 198 positions worth $16.2M, down 12% from $18.4M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
AustralianSuper deployed $1.07B of net new capital in Q2 2022, opening 16 new positions and adding to 100 existing holdings. Its largest new stake was Bio-Rad Laboratories Class A: 387,567 shares worth $192K.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Estee Lauder, an estimated $171M trimmed.
- AustralianSuper's largest Q2 2022 buy was Bio-Rad Laboratories Class A: 387,567 shares worth $192K.
- AustralianSuper added most to Intuit in Q2 2022, an estimated $255M increase.
- AustralianSuper's biggest Q2 2022 reduction was Estee Lauder, cutting an estimated $171M.
- AustralianSuper fully exited Goldman Sachs in Q2 2022, selling an estimated $86.5K.
- AustralianSuper's ten largest holdings make up 35% of its $16.2M portfolio in Q2 2022.
- AustralianSuper opened 16 new positions and closed 23 in Q2 2022.
- AustralianSuper's portfolio value fell 12% quarter-over-quarter to $16.2M.
Based on AustralianSuper's 13F filing for Q2 2022, filed 13 Jul 2022.